These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11694909)

  • 21. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
    Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alosetron for irritable bowel syndrome.
    Lièvre M
    BMJ; 2002 Sep; 325(7364):555-6. PubMed ID: 12228116
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 24. Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
    Palmer JB
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12511473
    [No Abstract]   [Full Text] [Related]  

  • 25. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 26. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.
    Devanarayana NM; Rajindrajith S
    World J Gastroenterol; 2018 Jun; 24(21):2211-2235. PubMed ID: 29881232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment goals in irritable bowel syndrome.
    Kellow JE
    Int J Clin Pract; 2001 Oct; 55(8):546-51. PubMed ID: 11695076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New developments in the diagnosis and treatment of irritable bowel syndrome.
    Longstreth GF; Drossman DA
    Curr Gastroenterol Rep; 2002 Oct; 4(5):427-34. PubMed ID: 12228046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 30. A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    Bergmann K
    J Clin Pharm Ther; 2003 Apr; 28(2):151-3; author reply 153. PubMed ID: 12713613
    [No Abstract]   [Full Text] [Related]  

  • 31. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 33. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and care of irritable bowel syndrome in a community-based population.
    Yawn BP; Locke GR; Lydick E; Wollan PC; Bertram SL; Kurland MJ
    Am J Manag Care; 2001 Jun; 7(6):585-92. PubMed ID: 11439732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.
    Yoon SL; Grundmann O; Koepp L; Farrell L
    Altern Med Rev; 2011 Jun; 16(2):134-51. PubMed ID: 21649455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor function in irritable bowel syndrome.
    Camilleri M
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():8A-11A. PubMed ID: 10202201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.
    Pittler MH; Ernst E
    Am J Gastroenterol; 1998 Jul; 93(7):1131-5. PubMed ID: 9672344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zelnorm: new treatment available for women with IBS.
    Nursing; 2002 Oct; 32(10):24, 26. PubMed ID: 12400584
    [No Abstract]   [Full Text] [Related]  

  • 40. Eziopitant. Pfizer.
    Evangelista S
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1441-3. PubMed ID: 11890362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.